a
a
Weather:
No weather information available
HomeHealthGRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

Cancer Detection and Positive Predictive Value Substantially Higher Than the Previously Published PATHFINDER Study MENLO PARK, Calif., June 18, 2025 /PRNewswire/ — GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today…

No comments

Sorry, the comment form is closed at this time.

Translate »